Dr. Anthony Atala: Director of the Wake Forest Institute for Regenerative Medicine, Dr. Atala is renowned for his pioneering work in the lab-engineering of organ tissues, especially the bladder. His lab focuses on translating regenerative medicine technologies to patients.
Dr. Ellen Heber-Katz: A researcher at the Wistar Institute, Heber-Katz has made waves with her discoveries related to the regenerative capabilities of mice, suggesting pathways to enhance human regenerative capacities.
Dr. Deepak Srivastava: President of the Gladstone Institutes, his research has pivoted around cardiovascular regeneration. He’s recognized for his work in converting scar tissue in the heart into functioning cardiac cells after an injury.
Dr. Robert Lanza: Chief Scientific Officer of Astellas Institute for Regenerative Medicine, Lanza’s work has primarily revolved around stem cells and their potential in regenerative therapies, particularly retinal diseases.
Dr. Robin Lovell-Badge: Stationed at the Francis Crick Institute, he has made significant contributions to stem cell research and understanding the intricacies of sex determination in embryos, paving the way for targeted therapeutic strategies.
Dr. Sally Temple: Co-founder of the Neural Stem Cell Institute, her work elucidates the mechanisms of neural stem cells in the brain. This has potential implications for therapies in neurodegenerative diseases and brain injuries.
Dr. Alejandro Sánchez Alvarado: A principal investigator at the Stowers Institute for Medical Research, he has delved deep into understanding the regeneration mechanics in planarians, with hopes of extrapolating such capacities to humans.
Dr. Michael Levin: Leading the Allen Discovery Center at Tufts University, Levin’s research is unique, centering on bioelectrical signaling in cells and its role in regeneration. His work suggests that manipulating these signals can drive remarkable regenerative outcomes.
Dr. Masayo Takahashi: A prominent ophthalmologist and researcher at the RIKEN Institute, she pioneered the world’s first clinical trial that used induced pluripotent stem cells (iPSCs) to treat age-related macular degeneration.
Dr. Deepa Bhartiya: Stationed at the National Institute for Research in Reproductive Health in India, her work focuses on very small embryonic-like stem cells (VSELs) and their potential role in regeneration and treating various diseases.
